Company intelligence / Profile preview

Beacons Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Beacons Pharmaceuticals, founded in 1970 and headquartered in Singapore, is the country's largest manufacturer of generic pharmaceuticals. The company operates two PIC/S GMP-certified manufacturing facilities in Singapore and provides fully integrated contract pharmaceutical manufacturing services. It produces over 200 therapeutics across multiple dosage forms under its own brand name. The company also owns Beacons Technology Systems, which developed SPAH production space technology solutions. Its operations extend to Malaysia and China through subsidiaries/JVs.

Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

2 assets

Panamol

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Beacons Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacons Pharmaceuticals.